Skip to content
Ambey Laboratories logo

Ambey Laboratories

DHANSA NSE
₹27.55 −1.40 (−4.84%)
P/E
19.68
View as Markdown
MCP
Close 4 Nov 2026 ₹27.55 −11.45 −29.4% 1Y
Start ₹39.00

Key Fundamentals

SMEFertilizers & AgrochemicalsChemicals

Price-based figures as of · TTM

ROCE
9.97%
Debt to Equity
0.43
EPS (TTM)
₹1.40
Book Value
₹29.87
Market Cap
—
P/E (TTM)
19.68
P/B
0.92
ROE
8.75%
Dividend Yield
0.00%
EBITDA
₹12.20 Cr
52W High
₹47.00
52W Low
₹16.20
Day Range
₹27.55 – ₹27.55
Volume
2,000

Peer Comparison

Commodities › Chemicals › Pesticides & Agrochemicals

Ambey Laboratories peer comparison
UPL
₹529.0022.09₹43,728 Cr1.281.16%5.64%10.10%₹52,804 Cr₹2,323 Cr
PI Industries
₹2,187.0028.48₹33,248 Cr2.950.69%11.20%15.00%₹6,516 Cr₹1,164 Cr
Sumitomo Chemical
₹328.1028.24₹15,980 Cr4.430.41%17.60%23.50%₹3,192 Cr₹581 Cr
Bayer CropScience
₹3,249.9019.95₹14,602 Cr4.924.57%23.70%29.10%₹5,595 Cr₹733 Cr
Sharda Cropchem
₹677.959.77₹6,015 Cr1.882.23%23.20%30.20%₹5,357 Cr₹626 Cr
Dhanuka Agritech
₹942.7515.83₹4,217 Cr2.500.21%18.50%23.80%₹1,953 Cr₹268 Cr
Rallis
₹189.6717.23₹3,734 Cr1.681.58%10.20%14.10%₹2,962 Cr₹214 Cr
Ambey Laboratories (this company)
₹27.5519.68₹78 Cr0.920.00%8.75%9.97%₹132 Cr₹4 Cr
Dhansa Labs
₹27.55————6.51%7.99%——
Median 9 companies₹529.0019.82₹10,309 Cr2.190.93%11.20%15.00%₹4,275 Cr₹604 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

38 Weak

Data confidence 98/100

surveillance:ESM1

Category scores

Quality
30
Poor
Returns, margins, earnings quality 22% weight
Valuation
39
Weak
Cheap vs sector & own history 24% weight
Growth
39
Weak
Sales & profit trajectory 9% weight
Financial Health
50
Average
Solvency, leverage, coverage 9% weight
Momentum
60
Good
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 0.68 times its book value

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 60.5 to 112 days.
  • Working capital days have increased from 64.4 days to 126 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish3610
OscillatorsBullish162
Moving AveragesStrong Bullish208

Key readings

RSI (14)
53.77
Neutral
MACD (12,26,9)
−0.10
Bullish
SMA (50)
26.55
Bullish
SMA (200)
27.77
Bearish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2025; 1Y: fiscal year to Mar 2025 against Mar 2024.

Revenue

Revenue growth by window
3Y+15.51%
1Y+9.17%

Net profit

Net profit growth by window
3Y+7.72%
1Y−37.50%

Operating cash flow

Operating cash flow growth by window
3YTurned negative
1YOutflow widened by ₹21 Cr

Operating margin· change in pp

Operating margin growth by window
3Y−4.13 pp
1Y+0.13 pp

Trailing twelve months: The latest quarterly results are more than a year old.

Revenue by year

Revenue by year, ₹ crore
Mar 2021₹82.00 Cr
Mar 2022₹85.00 Cr
Mar 2023₹105 Cr
Mar 2024₹120 Cr
Mar 2025₹131 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2021₹10.00 Cr
Mar 2022₹4.00 Cr
Mar 2023₹5.00 Cr
Mar 2024₹8.00 Cr
Mar 2025₹5.00 Cr

Half-yearly Results

₹ Cr

Results for the period ended Mar 2026 were due by 30 May 2026 and are not in this table yet.

AMBEY half-yearly results, ₹ crore
Particulars Mar 2024Sep 2024Mar 2025Sep 2025
Sales
60
68
64
68
Expenses
56
62
60
62
Operating Profit
4
6
4
6
OPM %
7%
9%
6%
9%
Other Income
1
1
1
0
Interest
1
2
1
1
Depreciation
1
1
2
2
PBT
3
4
2
3
Tax %
33%
18%
25%
13%
Net Profit
2
3
2
3
EPS (₹)
0.94
1.19
0.73
1.05

Profit & Loss

₹ Cr
AMBEY profit and loss, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
82
85
105
120
131
132
Expenses
72
74
97
111
122
122
Operating Profit
10
10
8
9
10
10
OPM %
12%
12%
7%
8%
7%
7%
Other Income
1
1
3
1
2
1
Interest
4
3
2
2
3
2
Depreciation
3
3
3
2
3
4
PBT
3
5
6
6
6
5
Tax %
−235%
26%
5%
−40%
21%
—
Net Profit
10
4
5
8
5
4
EPS (₹)
211
20.11
29.52
4.13
1.92
1.78
Div. Payout %
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
AMBEY balance sheet, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
5
18
18
19
25
25
Reserves
−13
1
1
13
51
67
Borrowings
33
18
14
30
41
40
Other Liabilities
20
19
21
18
10
9
Total Liabilities
45
56
54
79
127
140
Fixed Assets
16
25
25
24
23
22
CWIP
1
0
0
4
16
17
Investments
0
0
1
1
0
0
Other Assets
28
31
28
51
88
101
Total Assets
45
56
54
79
127
140

Cash Flow

₹ Cr
AMBEY cash flow, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating
3
6
10
−13
−34
Investing
−1
−1
−4
−5
−14
Financing
−1
−5
−6
18
48
Net Cash Flow
0
0
0
0
0
Free Cash Flow
2
5
7
−18
−48
CFO/OP
23
47
120
−131
−347

Ratios

AMBEY financial ratios, annual
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
31
37
12
57
112
Inventory Days
—
—
78
75
99
Days Payable
—
—
74
54
22
Cash Conversion Cycle
31
37
17
78
189
Working Capital Days
−10
11
18
49
126
ROCE %
—
25%
22%
18%
10%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Ambey Laboratories insights

29 extracted metrics across FY21–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 65.05%
  • Public 26.79%
  • Others 8.16%

Pledge data not available

Change vs previous quarter

Documents

Frequently Asked Questions about Ambey Laboratories

What does Ambey Laboratories Ltd do?
Incorporated in 1985, Ambey Laboratories Ltd is in the business of manufacturing and distribution of agro and home hygiene products.
Where is Ambey Laboratories Ltd (DHANSA) listed?
Ambey Laboratories Ltd trades as DHANSA on the NSE.
Which sector does Ambey Laboratories Ltd belong to?
Ambey Laboratories Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the PE ratio of Ambey Laboratories Ltd?
Ambey Laboratories Ltd trades at a PE ratio of 19.68 as of 4 Nov 2026, on earnings per share of ₹1.4, against a book value of ₹29.87 per share.
What is the 52-week high and low of Ambey Laboratories Ltd?
Over the last 52 weeks Ambey Laboratories Ltd has traded between ₹16.2 and ₹47 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Ambey Laboratories Ltd?
Ambey Laboratories Ltd reported a return on equity of 8.75%. Its debt-to-equity ratio is 0.43.

Company Information

Incorporated in 1985, Ambey Laboratories Ltd is in the business of manufacturing and distribution of agro and home hygiene products.

Website ambeylab.com
Listed 11 Jul 2024
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/AMBEY.md for Ambey Laboratories Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Fertilizer & Agrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month